Closeout of four phase II Vanguard trials and patient rollover into a Large international phase III hiv clinical endpoint trial : Closeout issuesTAVEL, Jorge A; FOSDICK, Lisa.Controlled clinical trials. 2001, Vol 22, Num 1, pp 42-48, issn 0197-2456Article

Antiretroviral drug content in products from developing countriesPENZAK, Scott R; ACOSTA, Edward P; TURNER, Michele et al.Clinical infectious diseases. 2004, Vol 38, Num 9, pp 1317-1319, issn 1058-4838, 3 p.Article

Preferential survival of CD4+ T lymphocytes engineered with anti-human immunodeficiency virus (HIV) genes in HIV-infected individualsMORGAN, Richard A; WALKER, Robert; BUNNELL, Bruce A et al.Human gene therapy. 2005, Vol 16, Num 9, pp 1065-1074, issn 1043-0342, 10 p.Article

Safety and immunogenicity of a gag-pol candidate HIV-1 DNA vaccine administered by a needle-free device in HIV-1-seronegative subjectsTAVEL, Jorge A; MARTIN, Julie E; ROEDERER, Mario et al.Journal of acquired immune deficiency syndromes (1999). 2007, Vol 44, Num 5, pp 601-605, issn 1525-4135, 5 p.Article

Regulatory approvals in a large multinational clinical trial: the ESPRIT experienceMCNAY, Laura A; TAVEL, Jorge A; OSEEKEY, Karen et al.Controlled clinical trials. 2002, Vol 23, Num 1, pp 59-66, issn 0197-2456Article

Bovine apolipoprotein B-100 is a dominant immunogen in therapeutic cell populations cultured in fetal calf serum in mice and humansSAKAMOTO, Norihisa; TSUJI, Kazuhide; FOX, Bernard A et al.Blood. 2007, Vol 110, Num 2, pp 501-508, issn 0006-4971, 8 p.Article

Post-trial access to tested interventions : The views of IRB/REC chair, investigators, and research participants in a multinational HIV/AIDS studyPACE, Christine; GRADY, Christine; WENDLER, David et al.AIDS research and human retroviruses. 2006, Vol 22, Num 9, pp 837-841, issn 0889-2229, 5 p.Article

CD4 cell response to 3 doses of subcutaneous interleukin 2: Meta-analysis of 3 Vanguard studiesARDUINO, Roberto C; NANNINI, Esteban C; TAVEL, Jorge A et al.Clinical infectious diseases. 2004, Vol 39, Num 1, pp 115-122, issn 1058-4838, 8 p.Article